bupropion has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansard, MJ | 1 |
| Jackson, MJ | 1 |
| Smith, LA | 1 |
| Rose, S | 1 |
| Jenner, P | 1 |
1 other study available for bupropion and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
A major metabolite of bupropion reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets.
Topics: Animals; Bupropion; Callithrix; Dose-Response Relationship, Drug; Female; Levodopa; Male; Motor Acti | 2011 |